[HTML][HTML] Allopurinol therapy and HLA-B* 58: 01 genotype

L Dean, M Kane - 2020 - europepmc.org
Allopurinol (brand names Zyloprim, Aloprim) is a xanthine oxidase inhibitor that decreases
the production of uric acid. It is most commonly used to manage gout, tumor lysis syndrome …

[HTML][HTML] Tumor lysis syndrome: introduction of a cutaneous variant and a new classification system

PR Cohen, VG Prieto, R Kurzrock - Cureus, 2021 - ncbi.nlm.nih.gov
Tumor lysis syndrome, an oncological emergency, is characterized by laboratory parameters
such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia, as well as …

Increased risk of colorectal cancer in patients with chronic tophaceous gout: a population-based study

A Boustany, R Rahhal, J Mitri, S Onwuzo… - Arquivos de …, 2023 - SciELO Brasil
Background: Colorectal cancer is the third most common type of cancer in both men and
women and ranks second as the most common cause of cancer death in the United States …

Tumor Lysis Syndrome in a Patient with BRAFV600E Mutated Colon Cancer Treated with Cetuximab and Encorafenib

S Kasai, E Sato, C Sakaguchi, Y Sasaki - Internal Medicine, 2025 - jstage.jst.go.jp
Tumor lysis syndrome (TLS) is a fatal complication associated with chemotherapy. We
herein report a case of TLS in a 73-year-old woman with metastatic BRAFV600E mutated …

[HTML][HTML] Management of acute kidney injury in gastrointestinal tumor: An overview

YQ Su, YY Yu, B Shen, F Yang… - World Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Gastrointestinal tumors remain a global health problem. Acute kidney injury (AKI) is a
common complication during the treatment of gastrointestinal tumors. AKI can cause a …

Comment on" Effect of serum uric acid and gout on the incidence of colorectal cancer: A meta-analysis"

SW Lai - The American journal of the medical sciences, 2024 - pubmed.ncbi.nlm.nih.gov
Comment on "Effect of serum uric acid and gout on the incidence of colorectal cancer: A
meta-analysis" Comment on "Effect of serum uric acid and gout on the incidence of …

[HTML][HTML] Infection Masquerading As Spontaneous Tumor Lysis Syndrome

J DeSalvo, AL Rossetti - Cureus, 2023 - ncbi.nlm.nih.gov
Tumor lysis syndrome (TLS) is a life-threatening condition due to malignant tumor cell lysis
resulting in severe metabolic derangements that require prompt recognition and …

[PDF][PDF] Inhibitory oksydazy ksantynowej oraz ich znaczenie w praktyce klinicznej

GK Jakubiak - researchgate.net
Oksydaza ksantynowa jest enzymem szlaku katabolizmu puryn, który katalizuje reakcję
przekształcenia hipoksantyny do ksantyny oraz ksantyny do kwasu moczowego. Kwas …

Best supportive care とした後にspontaneous tumor lysis syndrome を発症した膵癌の1 剖検例

廣瀬雄紀, 上山知人, 菊田修, 鈴木禎房… - 日本消化器病学会 …, 2022 - jstage.jst.go.jp
抄録 74 歳男性. 膵尾部癌・多発肝転移のため化学療法を施行するも病勢進行し,
症状緩和の方針となっていた. 腹痛増悪のため救急受診し, 入院となった. 第 5 病日 …